IE
FENC icon

Israel Englander’s Fennec Pharmaceuticals FENC Stock Holding History

Israel Englander’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$283K Buy
+26,317
New +$215K ﹤0.01% 5144
2026
Q1 		– Sell
-24,402
Closed -$188K – 5912
2025
Q4 		$188K Buy
24,402
+12,325
+102% +$101K ﹤0.01% 5489
2025
Q3 		$113K Sell
12,077
-4,257
-26% -$36.9K ﹤0.01% 5676
2025
Q2 		$136K Buy
+16,334
New +$112K ﹤0.01% 5470
2024
Q4 		– Sell
-14,249
Closed -$71.2K – 6099
2024
Q3 		$71.2K Sell
14,249
-55,085
-79% -$319K ﹤0.01% 5644
2024
Q2 		$424K Buy
69,334
+10,800
+18% +$89.7K ﹤0.01% 4697
2024
Q1 		$651K Buy
58,534
+44,165
+307% +$443K ﹤0.01% 4627
2023
Q4 		$161K Buy
+14,369
New +$119K ﹤0.01% 5234
2023
Q3 		– Sell
-86,794
Closed -$766K – 6253
2023
Q2 		$766K Sell
86,794
-103,204
-54% -$858K ﹤0.01% 4234
2023
Q1 		$1.58M Buy
189,998
+62,709
+49% +$582K ﹤0.01% 3659
2022
Q4 		$1.22M Sell
127,289
-122,048
-49% -$1.08M ﹤0.01% 3962
2022
Q3 		$2.02M Buy
249,337
+11,945
+5% +$82K ﹤0.01% 3732
2022
Q2 		$1.34M Sell
237,392
-15,287
-6% -$88.7K ﹤0.01% 4102
2022
Q1 		$1.42M Sell
252,679
-4,938
-2% -$24.9K ﹤0.01% 4184
2021
Q4 		$1.13M Sell
257,617
-4
-0% -$30 ﹤0.01% 4298
2021
Q3 		$2.43M Sell
257,621
-147,151
-36% -$1.1M ﹤0.01% 3684
2021
Q2 		$2.95M Buy
+404,772
New +$2.7M ﹤0.01% 3460
2020
Q2 		– Sell
-19,180
Closed -$114K – 4279
2020
Q1 		$114K Buy
+19,180
New +$125K ﹤0.01% 3530
2019
Q3 		– Sell
-47,634
Closed -$191K – 4283
2019
Q2 		$191K Buy
+47,634
New +$202K ﹤0.01% 3770
2018
Q2 		– Sell
-92,658
Closed -$1.12M – 3900
2018
Q1 		$1.12M Buy
+92,658
New +$875K ﹤0.01% 2632

Other funds holding FENC

RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCA
Prospect Capital Advisors Sausalito, California $220M AUM 60.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Israel Englander's FENC Position: Q2 2026 in Review

Israel Englander opened a new position in Fennec Pharmaceuticals (FENC) in Q2 2026: 26,317 shares worth $283K. The stake represents ﹤0.01% of the portfolio and ranks #5144 among its holdings. This is a return to the name: Israel Englander previously reported a position in FENC as recently as Q4 2025.

Israel Englander first reported a position in FENC in Q1 2018 and has held it in 20 quarters since. The position peaked at $2.95M in Q2 2021. 104 funds tracked by Wall St. Rank hold FENC as of Q2 2026.

  • Israel Englander held 26,317 shares of Fennec Pharmaceuticals worth $283K as of Q2 2026.
  • Fennec Pharmaceuticals was a new Israel Englander position in Q2 2026.
  • Fennec Pharmaceuticals made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #5144 holding.
  • Israel Englander first reported a position in Fennec Pharmaceuticals in Q1 2018 and has held it in 20 quarters since.
  • Israel Englander's Fennec Pharmaceuticals position peaked at $2.95M in Q2 2021.
  • 104 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.